Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort
Simona Petrucci, Monia Ginevrino, Ilaria Trezzi, et al.
Movement Disorders (2020) Vol. 35, Iss. 11, pp. 2106-2111
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

The neuropsychiatry of Parkinson's disease: advances and challenges
Daniel Weintraub, Dag Aarsland, К. Ray Chaudhuri, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 89-102
Open Access | Times Cited: 161
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira
Cells (2022) Vol. 11, Iss. 8, pp. 1261-1261
Open Access | Times Cited: 135
Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus
Ines Debove, Steffen Paschen, Deborah Amstutz, et al.
Movement Disorders (2024) Vol. 39, Iss. 2, pp. 235-248
Open Access | Times Cited: 22
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
Matthew E. Gegg, Elisa Menozzi, Anthony H.V. Schapira
Neurobiology of Disease (2022) Vol. 166, pp. 105663-105663
Open Access | Times Cited: 48
Glucocerebrosidase mutations and Parkinson disease
Sophia R.L. Vieira, Anthony H.V. Schapira
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1105-1117
Open Access | Times Cited: 39
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues
Elisa Menozzi, Marco Toffoli, Anthony H.V. Schapira
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108419-108419
Open Access | Times Cited: 24
Genetics in Parkinson’s disease, state-of-the-art and future perspectives
Lucia Trevisan, Andrea Gaudio, Edoardo Monfrini, et al.
British Medical Bulletin (2024) Vol. 149, Iss. 1, pp. 60-71
Open Access | Times Cited: 9
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Male sex accelerates cognitive decline in GBA1 Parkinson’s disease
Stephanie Caminiti, Micol Avenali, Alice Galli, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD
Carlo Alberto Artusi, Leonardo Lopiano, Francesca Morgante
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3931-3931
Open Access | Times Cited: 52
Exploring the Genotype–Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers
Elisa Menozzi, Anthony H.V. Schapira
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 50
Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings
Daniele Guadagnolo, Maria Piane, Maria Rosaria Torrisi, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 47
A Practical Approach to Early-Onset Parkinsonism
Giulietta Riboldi, Emanuele Frattini, Edoardo Monfrini, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 1-26
Open Access | Times Cited: 45
GBA-associated PD: chances and obstacles for targeted treatment strategies
Günter U. Höglinger, Claudia Schulte, Wolfgang H. Jost, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1219-1233
Open Access | Times Cited: 35
Genetic architecture of Parkinson’s disease subtypes – Review of the literature
Jarosław Dulski, Ryan J. Uitti, Owen A. Ross, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 34
GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2044-2044
Open Access | Times Cited: 22
A Phase 1B Trial in GBA1‐Associated Parkinson's Disease of BIA‐28‐6156, a Glucocerebrosidase Activator
Jonas M. den Heijer, Annelieke C. Kruithof, Matthijs Moerland, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1197-1208
Open Access | Times Cited: 20
Are patients with GBA–Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort
Micol Avenali, Roberta Zangaglia, Giada Cuconato, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023), pp. jnnp-332387
Open Access | Times Cited: 20
A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator
Jonas M. den Heijer, Annelieke C. Kruithof, Guido van Amerongen, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 9, pp. 3561-3573
Open Access | Times Cited: 40
Parkinson’s Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering
Seung Hyun Lee, Sang‐Min Park, Sang Seok Yeo, et al.
Diagnostics (2022) Vol. 12, Iss. 1, pp. 112-112
Open Access | Times Cited: 25
The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson’s therapeutics
Juan Carlos Rubilar, Tiago F. Outeiro, Andrés D. Klein
Brain (2024) Vol. 147, Iss. 8, pp. 2610-2620
Closed Access | Times Cited: 5
Genetic mutations in Parkinson’s disease: screening of a selected population from North-Eastern Italy
Giulia Bonato, Angelo Antonini, Francesca Pistonesi, et al.
Neurological Sciences (2024)
Open Access | Times Cited: 5
Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases
Valentina La Cognata, Giovanna Morello, Sebastiano Cavallaro
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4820-4820
Open Access | Times Cited: 29
Association of gender and age at onset with glucocerebrosidase associated Parkinson’s disease: a systematic review and meta-analysis
Qinghua Li, Yajun Jing, Peng Lun, et al.
Neurological Sciences (2021) Vol. 42, Iss. 6, pp. 2261-2271
Closed Access | Times Cited: 27
Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
Laura Smith, Chiao‐Yin Lee, Elisa Menozzi, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top